OCSL Q2 Deep Dive: Margin Expansion Amid Lower Non-Accruals and Conservative Deployment

Business development company Oaktree Specialty Lending (NASDAQ:OCSL) met Wall Street’s revenue expectations in Q2 CY2026, but sales fell by 7.8% year on year to $69.43 million. Its non-GAAP profit of $0.37 per share was 3.7% above analysts’ consensus estimates.

Is now the time to buy OCSL? Find out in our full research report (it’s free for active Edge members).

StockStory’s Take

Oaktree Specialty Lending’s second quarter results reflected ongoing efforts to reduce portfolio risk and maintain balance sheet flexibility, even as revenue declined compared to last year. Management emphasized that the main drivers were lower non-accruals and selective investment deployment, highlighting the successful exit of several challenged positions, notably Thrasio. President Mathew Pendo commented, "More than 85% of the decline in non-accrual dollars over the past year is due to proceeds received and investments returning to accrual status," underscoring the company’s focus on capital recovery and risk control.

Looking ahead, Oaktree Specialty Lending’s priorities center around disciplined underwriting, careful capital allocation, and monitoring of market volatility. Management stated that the current environment presents a mix of opportunity and risk, with CEO Armen Panossian noting, “Our focus remains on the factors we can control: disciplined underwriting, portfolio management, and balance sheet flexibility.” The company plans to leverage its permanent capital structure to take advantage of potential market dislocations, while closely watching macroeconomic headwinds and evolving trends in private credit.

Key Insights from Management’s Remarks

Management attributed the quarter’s performance to a decline in non-accruals, progress in portfolio workouts, and maintaining a conservative leverage position despite a slower deal environment.

• Non-accruals reduced: The company exited five non-accrual positions over the last two quarters, bringing non-accruals down to approximately 1.8% of the debt portfolio at fair value. This was primarily driven by loan repayments and investments returning to accrual status, with Thrasio’s asset sales as a significant contributor.
• Thrasio workout success: Asset sales at Thrasio, an Amazon aggregator, allowed Oaktree Specialty Lending to recover over 80% of its loans and return the remaining position to accrual status. Management highlighted this as an example of its workout expertise and ability to maximize recoveries through active engagement.
• Conservative leverage maintained: Net leverage ended the quarter at 1.02x, below the midpoint of the company’s target range. Management remains comfortable operating at this level to preserve capacity for future investments in a volatile market.
• Direct lending market dynamics: The private credit market saw less deal flow and wider spreads compared to previous years. Management noted that new deals are generally offering more lender-friendly terms, but competition for quality assets is starting to compress spreads again.
• Selective deployment and sector focus: The company continues to favor first lien senior secured debt, representing 82% of the portfolio’s fair value. Exposure to software, especially with high artificial intelligence risk, is being closely monitored and kept limited to manage potential disruption.

Drivers of Future Performance

Oaktree Specialty Lending’s outlook is shaped by evolving private credit market conditions, with management emphasizing the need for caution and readiness to deploy capital selectively.

• Market volatility and deal flow: Management expects continued volatility in private credit, influenced by macroeconomic uncertainty and a slow recovery in deal activity. CEO Armen Panossian stated that the firm is maintaining a defensive posture, ready to lean in when more attractive opportunities arise.
• Interest rate environment: Persistent inflation and uncertainty around future rate cuts mean that base rates may remain higher for longer. This supports higher income from floating rate loans but also increases the burden on borrowers, prompting close monitoring of interest coverage and leverage across the portfolio.
• Permanent capital advantage: Oaktree Specialty Lending’s status as a public business development company (BDC) with permanent capital allows it to avoid redemption pressures faced by non-traded BDCs. Management believes ongoing outflows from non-traded vehicles may reduce competition and create buying opportunities through secondary portfolio purchases or industry consolidation.

Catalysts in Upcoming Quarters

For upcoming quarters, the StockStory team is monitoring (1) the pace of further non-accrual reductions and successful portfolio workouts, (2) management’s ability to deploy capital as market volatility creates new opportunities, and (3) the impact of persistent high interest rates on borrower performance. Additionally, trends in private credit deal flow and outcomes from potential secondary portfolio purchases or industry consolidation will be key markers of execution.

Oaktree Specialty Lending currently trades at $12.07, in line with $12.13 just before the earnings. Is there an opportunity in the stock? The answer lies in our full research report (it’s free).

Now Could Be The Perfect Time To Invest In These Stocks

ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.

Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.